Teriflunomide-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome

Clin Exp Dermatol. 2021 Jan;46(1):166-169. doi: 10.1111/ced.14339. Epub 2020 Aug 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Crotonates / adverse effects*
  • Crotonates / therapeutic use
  • Dermatitis, Exfoliative / complications
  • Drug Hypersensitivity Syndrome / diagnosis*
  • Drug Hypersensitivity Syndrome / drug therapy
  • Drug Hypersensitivity Syndrome / etiology
  • Drug Hypersensitivity Syndrome / immunology
  • Edema / chemically induced
  • Edema / diagnosis
  • Eosinophilia
  • Exanthema / chemically induced
  • Exanthema / diagnosis
  • Face / pathology
  • Fatal Outcome
  • Female
  • Fever / diagnosis
  • Fever / etiology
  • Humans
  • Hydroxybutyrates / adverse effects*
  • Hydroxybutyrates / therapeutic use
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Liver Failure, Acute / complications
  • Multiple Sclerosis / drug therapy
  • Nitriles / adverse effects*
  • Nitriles / therapeutic use
  • Shock, Septic / complications
  • Skin Diseases / chemically induced
  • Skin Diseases / pathology*
  • Toluidines / adverse effects*
  • Toluidines / therapeutic use
  • Withholding Treatment

Substances

  • Crotonates
  • Hydroxybutyrates
  • Immunosuppressive Agents
  • Nitriles
  • Toluidines
  • teriflunomide